MUMBAI, India, March 13 -- Intellectual Property India has published a patent application (202611007548 A) filed by Chandigarh University, Mohali, Punjab, on Jan. 27, for 'a biosensor-based diagnostic system for detecting and monitoring neuronal ceroid lipofuscinoses (ncls).'
Inventor(s) include Dr. Gitanjali Gupta; Er. Jagmeet Kaur; and Er. Amandeep Kaur.
The application for the patent was published on March 13, under issue no. 11/2026.
According to the abstract released by the Intellectual Property India: "The present invention provides a non-invasive, wearable biosensor-based system for the early detection, subtype identification, and continuous monitoring of Neuronal Ceroid Lipofuscinoses (NCLs). The system integrates a multi-modal biosensor array comprising electrochemical sensors for neurochemical biomarkers, immunoassay sensors for lysosomal proteins, DNA hybridization sensors for CLN gene mutations, and optical fluorescence sensors for lipofuscin-like pigments. A microfluidic sampling module enables painless acquisition of saliva, sweat, or interstitial fluid, making the device suitable for pediatric use. Sensor outputs are processed through an embedded signal processing unit that performs real-time filtering, digitization, and preliminary biomarker analysis. An AI-driven diagnostic engine further interprets multimodal biomarker data, identifies abnormal patterns, and generates predictive alerts regarding disease onset or progression. The system incorporates a wireless communication interface for secure transmission of diagnostic data to a mobile application and cloud-based physician dashboard. A low-power power management unit enables continuous, long-term wearable operation."
Disclaimer: Curated by HT Syndication.
